NEWS

• Suvoda's Latest Release Creates An Experience Across Study Data, Patient Engagement, And Clinical Trial Operations

  Suvoda, a global clinical trial technology company, today announced a new release of important advancements since unifying the market-leading Suvoda and Greenphire products on one platform. 

• ISPOR Launches Its First Interpretive Report On The HARPER Template
• London Biotechnology Show 2026 To Unite Global Life Sciences Leaders, Innovators, Investors

  The London Biotechnology Show 2026 will return to ExCeL London on 18–19 November, bringing together biotechnology and pharmaceutical companies, researchers, healthcare professionals, investors, policymakers and technology providers to explore the breakthroughs and commercial opportunities shaping the future of life sciences.

• Suvoda Helps Patients Stay In Trials With More Travel Choice And Control Through Expanded Greenphire Travel

  Suvoda, a clinical trial technology company, today announced new capabilities in Greenphire Travel, its software and services dedicated to removing the logistical barriers that keep patients from participating in trials.

• Suvoda Makes Sofia AI Assistant Available For Clinical Trials To Drive Faster Answers And Action

  Sofia gives sponsors, CROs, and sites faster access to trial data and the ability to act on it—through AI built for regulated clinical research.

• Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation In Clinical Study

  Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), today reported interim results from a clinical study in which a proprietary artificial intelligence (AI) algorithm selected modified-release formulation compositions and doses during the trial. The algorithm reached the study's preset pharmacokinetic target within three dosing periods, meeting the program's interim objectives.

• Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy

  Avance Clinical, a global full-service CRO headquartered in Australia dedicated to servicing international biotechs, today announced the appointment of Tim Schuckman as its first Chief Commercial Officer (CCO). Schuckman joined the company on Monday 17 August in a newly created executive role that reflects Avance Clinical’s continued growth, deeper client partnerships, and expanding presence across North America, Asia, and Europe.

• Ypsomed Opens Production Site In China
• Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
• Ypsomed Expands Offering For Clinical Studies
• Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
• Ypsomed Receives FDA Clearance For SmartPilot
• Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform

  Signant Health announced its acquisition of Ametris (formerly ActiGraph), a global digital health solutions provider. This strategic acquisition unites industry-leading eCOA solutions with validated, wearable-derived digital outcome measures.

• Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026

  Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO) for biotechs, today announced a significant expansion of its Asia Pacific and China operations, reinforcing its position as the leading CRO partner for international biotech companies seeking access to the region’s diverse patient populations, scientific infrastructure, and accelerated clinical trial timelines.